BRIEF published on 11/22/2024 at 15:32, 1 year 1 month ago Eckert & Ziegler augmente ses prévisions financières pour 2024 Eckert & Ziegler Prévisions Financières Augmentation Des Ventes Croissance Du Résultat D'exploitation (EBIT) Entreprise 2024
BRIEF published on 11/22/2024 at 15:20, 1 year 1 month ago Xenetic Biosciences Shares Insights on DNase I Efficacy in Cancer Treatment Xenetic Biosciences Cancer Treatment Preclinical Data DNase I Immune Checkpoint Blockade
BRIEF published on 11/22/2024 at 15:20, 1 year 1 month ago Xenetic Biosciences partage ses connaissances sur l'efficacité de la DNase I dans le traitement du cancer Traitement Du Cancer Biosciences Xénétiques Données Précliniques ADNase I Blocage Du Point De Contrôle Immunitaire
BRIEF published on 11/22/2024 at 14:51, 1 year 1 month ago Vanguard Group Discloses Position in International Paper Company Form 8.3 Takeover Code Vanguard Group Stock Disclosure International Paper
BRIEF published on 11/22/2024 at 14:51, 1 year 1 month ago Le groupe Vanguard révèle sa position dans une société papetière internationale Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Stocks Document International
BRIEF published on 11/22/2024 at 14:50, 1 year 1 month ago The Vanguard Group Discloses Significant Interest in Centamin plc Takeover Code Securities Disclosure Vanguard Group Mining Sector Centamin Plc
BRIEF published on 11/22/2024 at 14:50, 1 year 1 month ago Le groupe Vanguard révèle une participation significative dans Centamin plc Groupe Vanguard Code De Prise De Contrôle Secteur Minier Divulgation Des Valeurs Mobilières Centamine Plc
BRIEF published on 11/22/2024 at 14:50, 1 year 1 month ago Jaguar Health Seeks Partner for Dog Diarrhea Drug NP300 FDA Approval Jaguar Health NP300 Dog Diarrhea Pet Connect Conference
BRIEF published on 11/22/2024 at 14:50, 1 year 1 month ago Jaguar Health recherche un partenaire pour le médicament NP300 contre la diarrhée canine Approbation De La FDA Santé Jaguar NP300 Diarrhée Du Chien Conférence Pet Connect
BRIEF published on 11/22/2024 at 14:49, 1 year 1 month ago The Vanguard Group Discloses Position in AngloGold Ashanti Takeover Code Securities Disclosure Vanguard Group AngloGold Ashanti Share Dealings
Published on 12/23/2025 at 20:45, 17 minutes ago Aeonian Closes Private Placement with Leading Strategic Investor Michael Gentile Acquiring 19.55% Stake
Published on 12/23/2025 at 18:20, 2 hours 42 minutes ago CANEX Metals Closes $3 Million Strategic Financing, Lead Investor Eric Fier is Now a Canex Insider, Momentum Building for Offer to Purchase Gold Basin
Published on 12/23/2025 at 15:29, 5 hours 33 minutes ago Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
Published on 12/23/2025 at 15:15, 5 hours 47 minutes ago NuRAN Announces Closing of the Restructuring Transaction and Initial Tranche of Additional Debt Settlements
Published on 12/23/2025 at 14:53, 6 hours 9 minutes ago Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces New CEO Investment
Published on 12/23/2025 at 19:21, 1 hour 41 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/23/2025 at 17:45, 3 hours 17 minutes ago Ordissimo SA: ORDISSIMO FINALISE L’acquisition de R-COST Et lance opérationnellement son nouveau pôle de services IT
Published on 12/23/2025 at 17:40, 3 hours 22 minutes ago UV GERMI : TENDANCES DE CHIFFRE D’AFFAIRES ET RESULTATS 2025
Published on 12/23/2025 at 12:48, 8 hours 14 minutes ago Evolution des droits de vote au 23 décembre 2025
Published on 12/23/2025 at 12:39, 8 hours 23 minutes ago CDA - Acquisition of Sport4lux in Luxembourg
Published on 12/23/2025 at 12:35, 8 hours 27 minutes ago CDA - Acquisition de Sport4lux au Luxembourg
Published on 12/22/2025 at 18:33, 1 day 2 hours ago ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 1 day 2 hours ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025